ask="14.50"
ask_size="600"
average_daily_volume="205306"
bid="9.35"
bid_size="1000"
book_value="3.69"
change="-0.50"
change_from_200_day_moving_average="-0.73"
change_from_50_day_moving_average="-2.16"
change_from_52_week_high="-4.90"
change_From_52_week_low="5.82"
change_in_percent="-4.90%"
close="9.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.53"
eps_estimate_next_year="-1.98"
ex_dividend_date="N/A"
float_shares="16060000"
high="10.18"
high_52_weeks="14.60"
last_trade_date="1/30/2017"
last_trade_price="9.70"
last_trade_size="6941"
last_trade_time="4:00pm"
low="9.56"
low_52_weeks="3.88"
market_capitalization="173.11M"
moving_average_200_day="10.43"
moving_average_50_day="11.86"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="29.25"
open="10.15"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-7.04%"
percent_change_from_50_day_moving_average="-18.19%"
percent_change_from_52_week_high="-33.56%"
percent_change_from_52_week_low="+150.00%"
previous_close="10.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.77"
price_per_sales="192.09"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="7.54"
stock_exchange="NCM"
symbol="STML"
volume="371555"
weeks_range_52="3.88 - 14.60"
